Video Experimental Relacionado
Updated: Jan 15, 2026
06:35
Cell Membrane Repair Assay Using a Two-photon Laser Microscope
Published on: January 2, 2018
13.4K
Inhibidor del Complemento C5 Ameliora un Caso de Disferlinopatía
Shuaikun Kang1,2,3, Qingqing Wang1,2,3, He Lv1,2,3
1Department of Neurology, Peking University First Hospital, Beijing, China.
Neurology(R) neuroimmunology & neuroinflammation
|January 13, 2026
Resumen
La terapia de inhibición del complemento mostró resultados prometedores para la disferlinopatía, una distrofia muscular. El tratamiento con eculizumab mejoró la fuerza, la movilidad y redujo el edema muscular del paciente, observándose beneficios sostenidos.
Área de la Ciencia:
- Neurología
- Inmunología
- Genética
Sus antecedentes:
- La disferlinopatía es una distrofia muscular grave relacionada con el gen DYSF.
- Los tratamientos actuales para la disferlinopatía son limitados.
- La evidencia sugiere que la activación del sistema del complemento juega un papel en la disferlinopatía.
Objetivo del estudio:
- Investigar el potencial terapéutico de la inhibición del complemento en la disferlinopatía.
- Evaluar la eficacia clínica del eculizumab en un paciente con disferlinopatía.
Principales métodos:
- Se realizó un estudio de caso único de un adolescente con disferlinopatía.
- La biopsia muscular confirmó la deficiencia de disferlina y la deposición de C5b-9.
- El paciente recibió tratamiento con eculizumab durante cuatro semanas.
Principales resultados:
- Se observó una mejora clínica significativa en la fuerza y la función muscular.
- La puntuación de la Escala North Star para la Disferlinopatía mejoró de 28 a 39.
- La distancia de la prueba de caminata de 6 minutos aumentó de 220 m a 363 m.
- La resonancia magnética muscular mostró una disminución del edema y los beneficios se mantuvieron durante 13 meses.
Conclusiones:
- La inhibición del complemento con eculizumab demostró beneficios clínicos prometedores en este caso de disferlinopatía.
- Se justifica una mayor investigación con cohortes más grandes para confirmar la eficacia y la seguridad.
Videos de Conceptos Relacionados
01:24Cystic Fibrosis: Management
467
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
467
01:21Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
01:11Fibril-associated Collagen
3.2K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.2K
01:23Cystic Fibrosis: Pathogenesis
710
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
710